Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Interest Income

Income earned on cash, deposits, and investments held by the company.

Aurora Cannabis Inc.NASDAQ: ACB

Interest Income · Q4 FY2026 · quarter ended Mar 2026

Interest income declines year over year

Q4 FY2026 interest income of CA$1.04M fell 59.7% year over year, behind the -42.6% change in trailing-twelve-month interest income. Sequentially, it rose 5.3% from the prior quarter. Over 3 fiscal years it compounded at -32.4% a year.

Context

  • Interest income amounted to 1.8% of revenue in FY2026, down 1.5 pp from a year earlier.
  • Interest income increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -59.7% toward the trailing-twelve-month pace of -42.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.04M+5.3% QoQ
Last fiscal yearMar 2026
CA$5.86M-49.0% YoY
LTMMar 2026
CA$6.6M-42.6% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-59.7%——
1 year-49.0%——
3-year CAGR-32.4%——
5-year CAGR——
10-year CAGR——

Interest Income history

CAD · from the income statement

Latest · FY2026
5.86M CAD
Year-over-year change
-49.0%
4-year CAGR
+6.8%

Interest Income vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -42.6% is the 5th highest of 6, against a peer median of +4.9%.
  • Interest income amounts to 2.1% of revenue for ACB, versus a peer median of 0.8%.
ACB Competitors
Interest Income for ACB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOABioAge Labs, Inc.LTM Mar 2026$12.64M USD+4.9%+204.2%122.5%
CGCCanopy Growth CorporationLTM Mar 2026CA$11.15M CAD+26.5%-25.6%3.6%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$6.99M USD-14.1%—83.5%
ACBAurora Cannabis Inc.LTM Mar 2026CA$6.6M CAD-42.6%-32.4%2.1%
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026$4.91M USD+17.7%-24.6%1.4%
OGIOrganigram Global Inc.LTM Mar 2026CA$459.35K CAD——0.2%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$401K USD——0.3%
LFMDLifeMD, Inc.LTM Mar 2026$80.56K USD——0.0%
TKNOAlpha Teknova, Inc.LTM Mar 2026$0 USD——0.0%
HITIHigh Tide Inc.LTM Apr 2026CA$0 CAD——0.0%
EDITEditas Medicine, Inc.LTM Mar 2026-$1.51M USD-112.9%+14.6%3.9%
Peer median (excluding ACB) —+4.9%-5.0%0.8%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.